[Ip-health] NHS sues Reckitt for £89m over Gaviscon supply - patent tricks...

Riaz K Tayob riaz.tayob at gmail.com
Mon Apr 18 12:09:19 PDT 2011

[Meanwhile for almost a decade the industry disregarded the data on 
h.pylori on ulcers, so their products could make money...]

NHS sues Reckitt for £89m over Gaviscon supply

Monday, 18 April 2011

The Health Secretary Andrew Lansley and the National Health Service are 
suing the consumer-goods group Reckitt Benckiser for £89m over the 
supply of Gaviscon, the company's heartburn medicine.

The case comes after Reckitt was fined £10.2m by the Office of Fair 
Trading (OFT) in October for admitting abuse of its dominant position in 
the supply of Gaviscon. The company admitted infringing British and 
European competition law by withdrawing its profitable Gaviscon Original 
Liquid from the National Health Service's prescription list after its 
patent expired in 2005. The move meant that prescriptions would be 
issued for Gaviscon Advance Liquid, which was protected by patent.

"Vigorous competition between firms supplying the public sector is vital 
to ensure taxpayers get the best value for money," the OFT's chief 
executive, John Fingleton, said when the fine was announced last year.

When contacted, Reckitt declined to comment on the Health Secretary's case.

More information about the Ip-health mailing list